EE200200248A - Adenosiini retseptori antagonistid ja nende valmistamise ja kasutamise meetodid - Google Patents
Adenosiini retseptori antagonistid ja nende valmistamise ja kasutamise meetodidInfo
- Publication number
- EE200200248A EE200200248A EEP200200248A EEP200200248A EE200200248A EE 200200248 A EE200200248 A EE 200200248A EE P200200248 A EEP200200248 A EE P200200248A EE P200200248 A EEP200200248 A EE P200200248A EE 200200248 A EE200200248 A EE 200200248A
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- methods
- receptor antagonists
- adenosine receptor
- adenosine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16528399P | 1999-11-12 | 1999-11-12 | |
PCT/US2000/031100 WO2001034604A2 (en) | 1999-11-12 | 2000-11-13 | Adenosine receptor antagonists and methods of making and using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200200248A true EE200200248A (et) | 2003-06-16 |
Family
ID=22598257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200200248A EE200200248A (et) | 1999-11-12 | 2000-11-13 | Adenosiini retseptori antagonistid ja nende valmistamise ja kasutamise meetodid |
Country Status (33)
Country | Link |
---|---|
US (4) | US6605600B1 (xx) |
EP (2) | EP1775297A3 (xx) |
JP (1) | JP2003513976A (xx) |
KR (1) | KR100845488B1 (xx) |
CN (1) | CN1187354C (xx) |
AT (1) | ATE353328T1 (xx) |
AU (1) | AU784528B2 (xx) |
BG (1) | BG106693A (xx) |
BR (1) | BR0015540A (xx) |
CA (1) | CA2390590C (xx) |
CY (1) | CY1106560T1 (xx) |
CZ (1) | CZ20021615A3 (xx) |
DE (1) | DE60033310T2 (xx) |
DK (1) | DK1230241T3 (xx) |
EA (1) | EA010260B1 (xx) |
EE (1) | EE200200248A (xx) |
ES (1) | ES2281367T3 (xx) |
GE (1) | GEP20043267B (xx) |
HK (1) | HK1049153B (xx) |
HU (1) | HUP0203371A3 (xx) |
IL (1) | IL149486A0 (xx) |
IS (1) | IS6380A (xx) |
MX (1) | MXPA02004795A (xx) |
NO (1) | NO20022237L (xx) |
NZ (2) | NZ519427A (xx) |
PL (1) | PL198156B1 (xx) |
PT (1) | PT1230241E (xx) |
SK (1) | SK6622002A3 (xx) |
TR (1) | TR200301062T2 (xx) |
UA (1) | UA77937C2 (xx) |
WO (1) | WO2001034604A2 (xx) |
YU (1) | YU33702A (xx) |
ZA (1) | ZA200203702B (xx) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI229674B (en) | 1998-12-04 | 2005-03-21 | Astra Pharma Prod | Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses |
SI1230243T1 (sl) * | 1999-11-12 | 2009-08-31 | Biogen Idec Inc | Policikloalkilpurini kot antagonisti adenozinskega receptorja |
BR0015540A (pt) * | 1999-11-12 | 2002-07-23 | Biogen Inc | Antagonistas do receptor de adenosina e métodos de preparação e uso dos mesmos |
WO2003105666A2 (en) * | 2002-06-12 | 2003-12-24 | Biogen, Inc. | Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
AU2003261206A1 (en) * | 2002-07-19 | 2004-02-09 | Aryx Therapeutics | Xanthine derivatives having adenosine a1-receptor antagonist properties |
US20040229901A1 (en) * | 2003-02-24 | 2004-11-18 | Lauren Otsuki | Method of treatment of disease using an adenosine A1 receptor antagonist |
JP3984281B2 (ja) * | 2003-04-14 | 2007-10-03 | ファイザー・プロダクツ・インク | 3−アザビシクロ〔3,2,1〕オクタン誘導体 |
RU2367442C2 (ru) * | 2003-04-25 | 2009-09-20 | Новокардия, Инк. | Способ нормализации мочеиспускания при нарушении функции почек |
CA2528385C (en) * | 2003-06-06 | 2011-03-15 | Endacea, Inc. | A1 adenosine receptor antogonists |
WO2007103776A2 (en) * | 2006-03-02 | 2007-09-13 | Cv Therapeutics, Inc. | A2a adenosine receptor antagonists |
CN101420958A (zh) * | 2006-04-06 | 2009-04-29 | 挪瓦卡尔迪阿公司 | 共投与腺苷a1受体拮抗剂和抗惊厥药 |
EP2018380B1 (en) | 2006-05-19 | 2011-10-19 | Abbott Laboratories | Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives |
JP2009540003A (ja) * | 2006-06-16 | 2009-11-19 | ノヴァカーディア,インク. | Aa1raの低頻度投与を含む腎機能の長期間にわたる改善 |
WO2008121882A1 (en) * | 2007-03-29 | 2008-10-09 | Novacardia, Inc. | Improved methods of administration of adenosine a1 receptor antagonists |
US20090197900A1 (en) * | 2007-03-29 | 2009-08-06 | Howard Dittrich | Methods of treating heart failure and renal dysfunction in individuals with an adenosine a1 receptor antagonist |
US20090228097A1 (en) * | 2008-03-07 | 2009-09-10 | Abbott Cardiovascular Systems Inc. | A1 Adenosine Receptor Antagonist-Coated Implantable Medical Device |
CN114790164B (zh) | 2021-08-13 | 2022-12-27 | 苏州璞正医药有限公司 | 一种取代的异吲哚啉-1,3-二酮类pde4抑制剂及其药物用途 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3155664A (en) * | 1959-11-13 | 1964-11-03 | Endo Lab | Derivatives of theophylline |
DE3843117A1 (de) | 1988-12-22 | 1990-06-28 | Boehringer Ingelheim Kg | Neue xanthinderivate mit adenosin-antagonistischer wirkung |
US5290782A (en) | 1989-09-01 | 1994-03-01 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives |
JPH06102662B2 (ja) * | 1989-09-01 | 1994-12-14 | 協和醗酵工業株式会社 | キサンチン誘導体 |
DE69033614T2 (de) | 1989-10-20 | 2001-04-19 | Kyowa Hakko Kogyo Kk | Kondensierte Purinderivate |
DE4019892A1 (de) | 1990-06-22 | 1992-01-02 | Boehringer Ingelheim Kg | Neue xanthinderivate |
CA2061544A1 (en) | 1991-02-25 | 1992-08-26 | Fumio Suzuki | Xanthine compounds |
CA2082325A1 (en) | 1991-11-08 | 1993-05-09 | Fumio Suzuki | Xanthine derivatives |
EP0556778A3 (en) | 1992-02-17 | 1993-11-24 | Kyowa Hakko Kogyo Kk | Xanthine derivatives |
US5342841A (en) | 1992-03-12 | 1994-08-30 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives |
TW252044B (xx) | 1992-08-10 | 1995-07-21 | Boehringer Ingelheim Kg | |
WO1994016702A1 (en) | 1993-01-26 | 1994-08-04 | Kyowa Hakko Kogyo Co., Ltd. | Remedy for irregular bowel movement |
US5395836A (en) | 1993-04-07 | 1995-03-07 | Kyowa Hakko Kogyo Co., Ltd. | 8-tricycloalkyl xanthine derivatives |
US5446046A (en) * | 1993-10-28 | 1995-08-29 | University Of Florida Research Foundation | A1 adenosine receptor agonists and antagonists as diuretics |
WO1998057645A1 (fr) | 1997-06-16 | 1998-12-23 | Kyowa Hakko Kogyo Co., Ltd. | Medicament contre l'oedeme hepatique |
AU7675498A (en) | 1997-06-16 | 1999-01-04 | Kyowa Hakko Kogyo Co. Ltd. | Preventive and remedy for drug-induced nephropathy |
DE19816857A1 (de) * | 1998-04-16 | 1999-10-21 | Boehringer Ingelheim Pharma | Neue unsymmetrisch substituierte Xanthin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
EP0955301A3 (en) * | 1998-04-27 | 2001-04-18 | Pfizer Products Inc. | 7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylcholine receptors |
ES2284256T3 (es) | 1998-07-02 | 2007-11-01 | Kyowa Hakko Kogyo Co., Ltd. | Medicamentos para la diabetes. |
BR0015540A (pt) * | 1999-11-12 | 2002-07-23 | Biogen Inc | Antagonistas do receptor de adenosina e métodos de preparação e uso dos mesmos |
SI1230243T1 (sl) * | 1999-11-12 | 2009-08-31 | Biogen Idec Inc | Policikloalkilpurini kot antagonisti adenozinskega receptorja |
-
2000
- 2000-11-13 BR BR0015540-3A patent/BR0015540A/pt not_active Application Discontinuation
- 2000-11-13 EA EA200200562A patent/EA010260B1/ru not_active IP Right Cessation
- 2000-11-13 NZ NZ519427A patent/NZ519427A/en not_active IP Right Cessation
- 2000-11-13 SK SK662-2002A patent/SK6622002A3/sk unknown
- 2000-11-13 UA UA2002064854A patent/UA77937C2/uk unknown
- 2000-11-13 PL PL356044A patent/PL198156B1/pl not_active IP Right Cessation
- 2000-11-13 EE EEP200200248A patent/EE200200248A/xx unknown
- 2000-11-13 DE DE60033310T patent/DE60033310T2/de not_active Expired - Lifetime
- 2000-11-13 CZ CZ20021615A patent/CZ20021615A3/cs unknown
- 2000-11-13 ES ES00983698T patent/ES2281367T3/es not_active Expired - Lifetime
- 2000-11-13 AU AU20421/01A patent/AU784528B2/en not_active Ceased
- 2000-11-13 JP JP2001536551A patent/JP2003513976A/ja active Pending
- 2000-11-13 CN CNB008161984A patent/CN1187354C/zh not_active Expired - Fee Related
- 2000-11-13 WO PCT/US2000/031100 patent/WO2001034604A2/en active IP Right Grant
- 2000-11-13 DK DK00983698T patent/DK1230241T3/da active
- 2000-11-13 CA CA2390590A patent/CA2390590C/en not_active Expired - Fee Related
- 2000-11-13 IL IL14948600A patent/IL149486A0/xx unknown
- 2000-11-13 KR KR1020027006022A patent/KR100845488B1/ko not_active IP Right Cessation
- 2000-11-13 YU YU33702A patent/YU33702A/sh unknown
- 2000-11-13 AT AT00983698T patent/ATE353328T1/de active
- 2000-11-13 US US09/711,554 patent/US6605600B1/en not_active Expired - Fee Related
- 2000-11-13 EP EP06026675A patent/EP1775297A3/en not_active Withdrawn
- 2000-11-13 TR TR2003/01062T patent/TR200301062T2/xx unknown
- 2000-11-13 EP EP00983698A patent/EP1230241B1/en not_active Expired - Lifetime
- 2000-11-13 HU HU0203371A patent/HUP0203371A3/hu unknown
- 2000-11-13 PT PT00983698T patent/PT1230241E/pt unknown
- 2000-11-13 MX MXPA02004795A patent/MXPA02004795A/es active IP Right Grant
- 2000-11-13 GE GEAP20006495A patent/GEP20043267B/en unknown
-
2002
- 2002-05-09 ZA ZA200203702A patent/ZA200203702B/xx unknown
- 2002-05-10 NO NO20022237A patent/NO20022237L/no not_active Application Discontinuation
- 2002-05-10 IS IS6380A patent/IS6380A/is unknown
- 2002-05-13 BG BG106693A patent/BG106693A/bg unknown
- 2002-12-23 HK HK02109300.4A patent/HK1049153B/zh not_active IP Right Cessation
-
2003
- 2003-06-12 US US10/461,534 patent/US20030225038A1/en not_active Abandoned
- 2003-09-01 NZ NZ527918A patent/NZ527918A/en not_active IP Right Cessation
-
2005
- 2005-05-13 US US11/128,550 patent/US20050222179A1/en not_active Abandoned
-
2007
- 2007-05-04 CY CY20071100590T patent/CY1106560T1/el unknown
- 2007-07-27 US US11/829,269 patent/US20080004293A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1110512T1 (el) | Πολυκυκλοαλκυλοπουρινες ως ανταγωνιστες υποδοχεων αδενοσινης | |
CY1106560T1 (el) | Ανταγωνιστες υποδοχεα αδενοσινης και μεθοδοι κατασκευης και χρησης αυτων | |
CA2094702A1 (en) | Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents | |
CA2275686A1 (en) | Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors | |
ATE256126T1 (de) | 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen | |
NZ533358A (en) | 3,4-Dihydro-1H-isoquinolin-2-yl-derivatives for use as NK2 receptor antagonists | |
PT889044E (pt) | Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central | |
ATE321044T1 (de) | C-6 ringsubstituierte pyrido(1,2- a)benzimidazolderivate zur behandlung von störungen des zentralen nervensystems | |
NO20053612L (no) | 1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC1A | Change of owner name |